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Joubert Syndrome 2 (JBTS2) in Ashkenazi Jews
Is Associated with a TMEM216 Mutation
Simon Edvardson,1,9 Avraham Shaag,2,9 Shamir Zenvirt,3 Yaniv Erlich,5,6 Gregory J. Hannon,5,6
Alan L. Shanske,8 John Moshe Gomori,4 Joseph Ekstein,7 and Orly Elpeleg2,3,*
Patients with Joubert syndrome 2 (JBTS2) suffer from a neurological disease manifested by psychomotor retardation, hypotonia, ataxia,
nystagmus, and oculomotor apraxia and variably associated with dysmorphism, as well as retinal and renal involvement. Brain MRI
results show cerebellar vermis hypoplasia and additional anomalies of the fourth ventricle, corpus callosum, and occipital cortex.
The disease has previously been mapped to the centromeric region of chromosome 11. Using homozygosity mapping in 13 patients
from eight Ashkenazi Jewish families, we identified a homozygous mutation, R12L, in the TMEM216 gene, in all affected individuals.
Thirty individuals heterozygous for the mutation were detected among 2766 anonymous Ashkenazi Jews, indicating a carrier rate
of 1:92. Given the small size of the TMEM216 gene relative to other JBTS genes, its sequence analysis is warranted in all JBTS patients,
especially those who suffer from associated anomalies.Joubert syndrome (JBTS [MIM 213300]) is characterized
by a specific midhindbrain malformation, hypotonia,
cerebellar ataxia, and developmental delay. Oculomotor
apraxia and abnormalities in breathing patterns are
frequent findings. Associated anomalies include progres-
sive retinal degeneration,1 renal anomalies (nephronoph-
thisis, NPHP [MIM 256100]),2 both retinal and renal
involvement (cerebello-oculo-renal syndromes, CORS
[MIM 608091]),3 ocular colobomas and liver abnormalities
(COACH [MIM 216360]),4 and both orofacial and digital
signs (OFDVI [MIM 277170]).5 So far, Joubert syndrome
and related disorders (JSRDs) have been mapped to ten
loci, and causative genes have been identified for nine of
them.6–10 Most encoded proteins were shown to localize
to the cilia or to the centrosome, indicating that ciliary
dysfunction is a key factor in the molecular pathogenesis
of JSRDs.
We now report on a mutated gene in the tenth locus,
11p12-q13.3, in JSRD patients of Ashkenazi Jewish origin.
The subjects were 13 patients from eight Ashkenazi
Jewish families. Three of the families belonged to the
same clan. Pregnancy was uneventful in all cases, and
all the infants in this series were born at term, with
normal Apgar scores and appropriate weights for gesta-
tional age. In two cases, there was suspicion of posterior
fossa abnormalities on the basis of prenatal ultrasound.
The initial presentation, evident from birth, consisted of
hypotonia, rotatory nystagmus, esotropia, and feeding
difficulties due to oral motor dysfunction with associated
impaired swallowing and mastication. The physical exam-
ination was notable for dolichocephaly and frontal
bossing in six patients, metopic craniosynostosis in one
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The A41 cm) due to noncommunicating hydrocephalus in one
patient. Three patients had postaxial polydactyly in the
lower limbs, and two patients had it in their upper limbs
as well.
Early psychomotor development was invariably delayed,
and the cognitive functioning of all the patients was even-
tually in the mildly to severely retarded range. Over the
first two years of life, the nystagmus improved in all the
patients, and visual function, funduscopic examination,
and visual evoked potential appeared normal thereafter.
Oral motor difficulties were invariably present from birth,
resulting in swallowing and chewing difficulties and, in
most patients, failure to thrive. Serum transaminases
were normal in all the patients. In eight patients, normal
renal ultrasound was reported. However, two patients
suffered from end-stage renal insufficiency since midado-
lescence (the clinical data are summarized in Table 1). In
brain MRIs, the molar tooth sign (deep interpeduncular
fossa; thick, elongated superior cerebellar peduncles and
cerebellar vermis hypoplasia) was observed. Associated
findings, a complete absence of the vermis with wide space
between the cerebellar hemisphere or a dysplastic split
vermis without an opening or separation of the cerebellar
hemispheres were present in all of the patients (Figure 1).
Over the years, the patients underwent extensive meta-
bolic and genetic investigations, including array compara-
tive genomic hybridization, all of which yielded normal
results.
Because the clinical and radiological findingswere consis-
tentwith the diagnosis of JBTS, sequence analysis of known
JSRD genes (CEP290 [MIM 610142], TMEM67/MKS3
[MIM 609884], RPGRIP1L [MIM 610937], ARL13B [MIM
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Table 1. Summary of Clinical Data
Patient Sex Current Age PMR
Abnormal Eye
Movements Hypotonia Polydactily
Abnormal
Renal Function Other Clinical Features
1 M 9 yrs mild rotatory nystagmus,
esotropia
þ   dolichocephaly,
frontal bossing
2 F 3 yrs mod rotatory nystagmus,
esotropia
þ   dolichocephaly, frontal
bossing, oromotor difficulties
3 F 2 yrs mod rotatory nystagmus þ   dolichocephaly, frontal
bossing, oromotor difficulties
4 M 2 yrs mod rotatory nystagmus þ   oromotor difficulties
5 M 1 yr dev.delay rotatory nystagmus,
esotropia
þ both feet  oromotor difficulties,
metopic craniosynostosis
6 F 5 yrs mod rotatory nystagmus þ   oromotor difficulties,
dolichocephaly,
frontal bossing
7 M 12 yrs severe rotatory nystagmus,
esotropia
þ   hydrocephalus
8 M 1 yr dev. delay rotatory nystagmus,
esotropia
þ   oromotor difficulties,
dolichocephaly, frontal
bossing, hypothyroidism
9 F 17 yrs severe rotatory nystagmus þ  renal insufficiency,
renal transplantation
epilepsy, retinopathy
10 F 2 yrs severe rotatory nystagmus þ  
11 M 26 yrs severe  þ upper and lower limbs renal insufficiency,
peritoneal dialysis
short limbs, dolichocephaly,
frontal bossing,
oromotor difficulties
12 M 16 yrs severe nystagmus þ upper and lower limbs  
13 M 2 yrs mod rotatory nystagmus þ   
Abbreviations are as follows: m,male; f, female; mod, moderate; dev. delay, developmental delay; PMR, psychomotor retardation.þ indicates present, indicates
negative or absent.was performed in three patients but invariably yielded
normal results.
In order to localize the mutated gene, we performed
homozygosity mapping, using the GeneChip Human
Mapping 250K Nsp Array of Affymetrix, as previously
described.11 This study was initiated by the Dor Yeshorim
organization at the request of families of patients affected
with JBTS, and all patients’ guardians provided informed
consent for participation, in compliance with the research
regulations regarding human subjects in Israel. Initially,
the DNA samples of three second cousins originating94 The American Journal of Human Genetics 86, 93–97, January 8, 20from a single clan were analyzed. Comparing runs of
homozygosity longer than 2.4 Mb in each patient, we de-
tected only one homozygous region, spanning 4.46 Mb
on chromosome 11 (SNP markers rs11228951–
rs11230775, corresponding to 56.73–61.19 Mb; marker
positions are provided in accordance with the March
2006 release of the UCSCHumanGenome Assembly; build
hg18), which was shared by the three patients; the geno-
types of the 379 SNP markers that are included in this
region were identical. We then analyzed the DNA samples
of three additional patients originating from two unrelatedFigure 1. Magnetic Resonance Images
of the Patients, Illustrating the Typical
Anomalies
(A and B) Axial T2-weighted images
showing (A) a completely absent vermis
with a wide space between the cerebellar
hemispheres (arrow) and (B) a dysplastic
split vermis (arrow) without an opening
or separation of the cerebellar hemi-
spheres.
(C) Midsagittal T1-weighted image
showing cystic dilatation of the fourth
ventricle (arrow) and vermian hypoplasia.
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Figure 2. The Homozygous Regions and the TMEM216 Muta-
tion
(A) Homozygous regions of the six SNP-genotyped patients (blue
rectangles) within the chromosome 11 centromeric region.
(B) Chromatograms showing the sequence of exon 3, the first
coding exon, of the TMEM216 gene. 1, a normal control;. 2, a
patient homozygous for the c.35G>T mutation (arrow); 3, an
obligatory carrier of the mutation.families. These patients shared a 2.3 Mb homozygous
region on chromosome 11 (SNP markers rs612386–
rs7126715, corresponding to 60.71–62.94 Mb) (Figure 2).
Notably, the six patients shared identical genotypes within
theoverlappinghomozygous interval anddidnot share any
other genomic region. The overlapping segment (60.71–
61.19 Mb on chromosome 11) included 14 open reading
frames (PGA3 [MIM 169710], PGA4 [MIM 169720], PGA5
[MIM 169730], VWCE [MIM 611115], DDB1 [MIM
600045], DAK, CYBASC3, TMEM138, TMEM216, CPSF7,
C11orf79 [MIM 613019], C11orf66, LRRC10L, and SYT7
[MIM 604146]), and we have determined the sequence
of their 117 coding exons and their flanking intronic
sequences. This analysis resulted in the identification of a
singlemutation in the TMEM216 gene, c.35G>T (Figure 2),
which is predicted to result in the substitutionof arginine at
codon 12 by leucine (R12L). In parallel, we took a comple-
mentary approach, determining the complete exonic
sequence of a mother and an affected daughter by using
array-based hybrid selection and deep sequencing.12,13
Genomic DNA samples were fragmented and immortalized
by ligation to standard Illumina adapters, followed by
PCR-based enrichment. Sequences corresponding to all
annotated human exons were enriched by hybridization
to an Agilent 1 Million Feature Array.14 Each sample was
sequenced in two flow cell lanes on a GAIIx (Illumina),
which yielded roughly 30 million paired-end sequence
readsper sample.Our analysis didnot reveal anypotentially
relevant insertions or deletions in the targeted region. We
called SNPs with SOAPsnp, using a coverage cutoff of atThe Aleast 53 in the 59–62 Mb region on chromosome 11.15
All SNPs that were not homozygous in the daughter
and heterozygous in the mother were discarded. Only
17 SNPs survived this filter (Table S1, available online).
Excluding SNPs that were already documented in
dbSNP130 reduced the number of candidates to two.
One had an obvious effect on a protein, changing amino
acid 12 of TMEM216 from arginine to leucine. This was
precisely the coding variant identified via combined
linkage mapping and candidate resequencing. Thus, not
only did these analyses independently support our candi-
date gene, but they also failed to reveal any similarly
compelling potentially causal mutation. The R12L muta-
tion was present in a homozygous state in all 13 patients.
Carriers were detected via three different methods. First,
direct sequencing was used as described above. Second,
restriction fragment length polymorphism (RFLP) anal-
ysis was performed, whereby a 176 bp fragment was
amplified via mismatch primer amplification (forward
primer 50-CCCAAGTGTGTGGCAGTTC-30, reverse primer
50-GGACAACACTTACCAAAAAACTGG-30), followed by
BpmI digestion at 37C for 2 hrs. In the presence of the
mutation, the 176 bp fragment was digested to 136 bp
and 40 bp fragments, which were then analyzed on 2%
agarose gel. Finally, for mass carrier detection, we used
the TaqMan Allelic Discrimination method with the
forward primer 50-GTGATGCTCCTCCTTTATCTTGGAA-30,
reverse primer 50- GGAGTGGAAATATTCTCTGGACAA
CA-30, and the following reporter probes: wild-type, VIC
probe 50-AAGTAATTCGCCTGTTTTT-30; mutant, FAM
probe 50-TGAAGTAATTCTCCTGTTTTT-30. The analysis
was performed on a 7900HT Real-Time PCR System
with SDS version 2.3 software (Applied Biosystems). With
these methods used, heterozygosity for the mutation was
detected in all of the parents, in 12 of 20 siblings, 23 of
48 first-degree cousins, 58 of 449 more-remote relatives,
and30of 2766 anonymous individuals of Ashkenazi Jewish
origin, indicating a carrier rate of 1:92 for the R12L muta-
tion in this ethnic group.
JSRDs were heretofore mapped to ten loci, and causative
genes have been identified for nine of them. The tenth
locus, the centromeric region of chromosome 11 (11p12-
q13.3), was mapped in six families, and this form was
designated as JBTS2 (MIM 608091). The patients, origi-
nating from Sicily, Turkey, Pakistan, United Arab Emirates,
and Portugal, suffered from a neurological disease with
psychomotor retardation, breathing abnormalities in
infancy (alternating brady-tachypnea), hypotonia, truncal
ataxia, nystagmus, oculomotor apraxia, and impaired
pursuit and saccades. Brain MRI showed the molar tooth
sign variably associated with fourth-ventricle cyst, kinked
corpus callosum, malformed occipital cortex, and hydro-
cephalus. Miscarried siblings had occipital encephalocele
and enlarged cistern magna. Ophthalmologic abnormali-
ties included microphthalmia, retinal coloboma, retinal
dystrophy, and optic atrophy. Renal involvement ranged
in severity from a urinary-concentration defect secondarymerican Journal of Human Genetics 86, 93–97, January 8, 2010 95
to nephronophthisis to fulminent renal failure due to
cystic renal dysplasia. Facial dysmorphism with hyperte-
lorism, low-set ears, and a depressed nasal bridge, as well
as postaxial polydactyly, were reported.2,16,17 The critical
region on chromosome 11 was initially bordered by
D11S1993–D11S1883, corresponding to 43.65–63.13
Mb.2 Mapping of additional families narrowed the region
further to 46.12–63.13 Mb (D11S1344–D11S1883).17
Although we did not have the opportunity to analyze
the TMEM216 gene sequence in the original JBTS2
patients, the clinical and radiological similarity and the
overlapping critical regions suggest that JBTS2 is caused
by mutations in the TMEM216 gene.
The three coding exons of the TMEM216 (HSPC244)
gene encode a small protein that consists of 87 amino
acids, predicted to form two transmembrane domains.
The amino acid arginine at codon 12 is conserved in
the TMEM216 homologs in Danio rerio and Drosophila
melanogaster, and its substitution by leucine is predicted to
be deleterious by both the SIFT-BLink software and the
PolyPhen software. The segregation of the mutation with
the disease state in all family members and the absence of
mutations in all other coding exons within the linked
region suggest that this mutation is indeed pathogenic.
Because all known JSRD genes were shown to localize to
the primary cilia or basal body or to directly interact with
their components (reviewed in Doherty18), it is tempting
to speculate a similar localization for the TMEM216
protein. Ciliary membranes contain receptors and ion-
channel proteins mediating mechano- and chemosensa-
tions and other types of cell signaling, including Shh,
Wnt, and PDGF-alpha signaling pathways. TMEM67/
MKS3 (Meckelin), a JSRD protein with seven transmem-
brane domains, was shown to localize both to the primary
cilium and to the plasma membrane in ciliated cell lines
and primary cells and to be of importance for centriole
migration to the apical membrane and for the consequent
formation of the primary cilium.19 The elucidation of the
role of the TMEM216 protein in this organelle and in
JSRD2 pathogenesis is in progress. Given its small size in
comparison to other JSRD genes, sequence analysis of
TMEM216 is warranted in every JSRD patient, especially
those who suffer from associated anomalies.Supplemental Data
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